CRUK Publication update- National SACT Multiple Myeloma regimen specific consent forms

Dear All,

I am delighted to inform you that the first phase of Multiple Myeloma regimen specific SACT consent forms are available for use on the CRUK website.

All forms can be found here

Given the substantial number of treatment regimens for Multiple Myeloma, we are releasing the forms in two phases. Consent forms for the commonly used regimens have been prioritised and uploaded in the first phase. The remaining forms are in progress and will be available in due course as part of the second phase.

Please share this update with your clinical teams or forward to the appropriate lead cancer clinician in your organisation.

Any questions, please do let me know.

Best wishes,
Alia
Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA Executive Committee on 9th October 2024

Proposed BOPA Vision – We want to hear from you! Have your say today

Do you feel reflected in BOPA’s values, mission and vision? Would you add anything else?  Please contact us now – Feedback on the Proposed Vision (office.com) The Vision can be…

Read article
By BOPA Committee on 8th October 2024

UKMS Pharmacy Group – Education Day, November 5th 2024

The UK Myeloma Society Pharmacy Group (a special-interest group affiliated to BOPA) is running its 2nd Annual Educational Meeting on Tuesday 5th November from 12 Noon to 4.30pm. The meeting…

Read article
By BOPA research subcommittee on 8th October 2024

Survey: Clinical Research Priorities for UK Cardio-Oncology

Dear members, The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is a new project bringing cardiology and oncology specialists together with patient representatives. Its aims are to inform cardio-oncology research priorities,…

Read article
By BOPA on 4th October 2024

Survey request for members thinking about credentialing as a Consultant Pharmacist

In May 2024 – if you had any intentions to start, re-submit, or progress your consultant portfolio within the next 18-24 months please complete this survey. You do not need…

Read article